Market Value1,899,346,535
Total Holdings72
File Date2025-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
EXAS / Exact Sciences Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
NYXH / Nyxoah SA
ARCT / Arcturus Therapeutics Holdings Inc.
URGN / UroGen Pharma Ltd.
ESTA / Establishment Labs Holdings Inc.
ITOS / iTeos Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
KNSA / Kiniksa Pharmaceuticals, Ltd.
LQDA / Liquidia Corporation
RARE / Ultragenyx Pharmaceutical Inc.
IMVT / Immunovant, Inc.
SRPT / Sarepta Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
IONS / Ionis Pharmaceuticals, Inc.
VYGR / Voyager Therapeutics, Inc.
MDT / Medtronic plc
BDX / Becton, Dickinson and Company
ZBH / Zimmer Biomet Holdings, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ZYME / Zymeworks Inc.
GMED / Globus Medical, Inc.
ANRO / Alto Neuroscience, Inc.
SRRK / Scholar Rock Holding Corporation
STRO / Sutro Biopharma, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
XENE / Xenon Pharmaceuticals Inc.
IMTX / Immatics N.V.
GEHC / GE HealthCare Technologies Inc.
GERN / Geron Corporation
TRAW / Traws Pharma, Inc.
FOLD / Amicus Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
TVTX / Travere Therapeutics, Inc.
LNTH / Lantheus Holdings, Inc.
TSHA / Taysha Gene Therapies, Inc.
MGNX / MacroGenics, Inc.
VRDN / Viridian Therapeutics, Inc.
QURE / uniQure N.V.
OKUR / OnKure Therapeutics, Inc.
NUVL / Nuvalent, Inc.
PRGO / Perrigo Company plc
VERA / Vera Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
BCAX / Bicara Therapeutics Inc.
ACLX / Arcellx, Inc.
KALV / KalVista Pharmaceuticals, Inc.
CDTX / Cidara Therapeutics, Inc.
ATRA / Atara Biotherapeutics, Inc.
DHR / Danaher Corporation
ARQT / Arcutis Biotherapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
SVRA / Savara Inc.
COGT / Cogent Biosciences, Inc.
SLDB / Solid Biosciences Inc.
PASG / Passage Bio, Inc.
MLTX / MoonLake Immunotherapeutics
CLDX / Celldex Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ALEC / Alector, Inc.
ATXS / Astria Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
TYRA / Tyra Biosciences, Inc.
ENGN / enGene Holdings Inc.
DAWN / Day One Biopharmaceuticals, Inc.
TENX / Tenax Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
BRKR / Bruker Corporation
JAZZ / Jazz Pharmaceuticals plc
ALC / Alcon Inc.
LXEO / Lexeo Therapeutics, Inc.
APLT / Applied Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
TMO / Thermo Fisher Scientific Inc.
COO / The Cooper Companies, Inc.
IRON / Disc Medicine, Inc.
EW / Edwards Lifesciences Corporation
ABT / Abbott Laboratories
ELVN / Enliven Therapeutics, Inc.
BBNX / Beta Bionics, Inc.